Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 (APP21)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
Lubaroff, David M, University of Iowa
ClinicalTrials.gov Identifier:
NCT00583752
First received: December 20, 2007
Last updated: September 11, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)